Industry Outlook and Trend Analysis
The Preventive Healthcare Technologies and Services Market was worth USD 80.72 billion in 2014 and is expected to reach approximately USD 185.26 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.67% during the forecast period. Preventive healthcare services incorporates measures made for taking preventative steps of illnesses caused either by analysis of the sickness or immunization. The diseases that are identified or immunized boundlessly are cardiovascular issues, perpetual respiratory ailment, different complexities, certain infectious sicknesses, and diabetes. These technologies assist in taking action for avoiding sicknesses by diagnosing the issue in time. Preventive healthcare technological advancements and facilities are massively prominent because of rising rates of constant respiratory ailments, cardiovascular sicknesses, and certain solution or eliminating errors.
Type Outlook and Trend Analysis
Currently, early detection and screening technologies holds the biggest share of the overall industry because of key drivers, for example, expanding discovery of drugs and development activities being performed for the fabrication of novel medication formulations and technological progression in pharmacogenomics portion bringing about rising interest for customized medicines. Personalized medicine is anticipated to be the quickest developing sub-fragment in the early detection and technologies market. Latest technologies are anticipated to diminish errors that exhibit a promising forecast of sales and will be the quickest developing business sector significantly because of components, for example, stringent administrative rules to adopt and execute cGMP and cGLP rules amid creation exercises to accomplish immaculate outcomes in product quality confirmation and approval.
Regional Outlook and Trend Analysis
In 2016 North America was seen to be the biggest preventive healthcare technologies and services market. North America overwhelmed the worldwide market as the district is driven by factors, for example, rising frequency of chronic diseases, efforts made by the government proactively to encourage drug development and discovery, and presence of leading players in the region. The market development in Europe is principally credited to increment in the vital organization between research academia and healthcare segment. Asia Pacific is assessed to be the quickest developing local portion over the forecast period.
The leading players in the market are Lifecom Pharmaceuticals Private Limited, Scriptpro LLC, Dilon Technologies Inc, Sanofi, Omnicell Technologies, OMRON HEALTHCARE Co Ltd, Merck & Co, Medtronic, Myriad Genetics and NOVX Systems Corp. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Preventive Healthcare Technologies and Services Market is segmented as follows-
Infectious Diseases Vaccine
Chronic Disease Management Technologies
Blood Pressure Monitors
Advanced Technologies to Reduce Errors
Smart Infusion Pumps
Computerized Provider Order Entry System
Smart Packaging and Automated Prescription Formulation and Dispensing
Clinical Decision Supports System
Early Detection and Screening Technologies
Other Screening Technologies
Rest of Europe
Rest of Asia-Pacific
Rest of South America
Middle East and Africa
Rest of MEA
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?